GT
AMRX icon

Glenmede Trust’s Amneal Pharmaceuticals AMRX Stock Holding History

Glenmede Trust’s Portfolio AMRX Stock Details AMRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-114
Closed – – 2435
2020
Q1 		$0 Hold
114
– – ﹤0.01% 3000
2019
Q4 		$0 Hold
114
– – ﹤0.01% 3004
2019
Q3 		$0 Hold
114
– – ﹤0.01% 3003
2019
Q2 		$0 Hold
114
– – ﹤0.01% 3056
2019
Q1 		$1K Hold
114
– – ﹤0.01% 2906
2018
Q4 		$1K Sell
114
-5,365
-98% -$96.7K ﹤0.01% 2856
2018
Q3 		$120K Sell
5,479
-184
-3% -$3.87K ﹤0.01% 1268
2018
Q2 		$93K Buy
+5,663
New +$99.4K ﹤0.01% 1272

Other funds holding AMRX

FI
Fosun International Hong Kong, China $446M AUM 13.33% 1-Year Est. Return
TGHSA
TPG Group Holdings (SBS) Advisors Fort Worth, Texas $10.1B AUM 22.58% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

Glenmede Trust's AMRX Position: Q2 2020 in Review

Glenmede Trust sold out of Amneal Pharmaceuticals (AMRX) in Q2 2020, closing a stake of 114 shares.

Glenmede Trust first reported a position in AMRX in Q2 2018 and held it in 8 quarters. The position peaked at $120K in Q3 2018. 139 funds tracked by Wall St. Rank hold AMRX as of Q2 2020.

  • Glenmede Trust reported no remaining Amneal Pharmaceuticals position as of Q2 2020 after selling out during the quarter.
  • Glenmede Trust sold 114 Amneal Pharmaceuticals shares in Q2 2020.
  • Glenmede Trust first reported a position in Amneal Pharmaceuticals in Q2 2018 and held it in 8 quarters.
  • Glenmede Trust's Amneal Pharmaceuticals position peaked at $120K in Q3 2018.
  • 139 funds tracked by Wall St. Rank held Amneal Pharmaceuticals as of Q2 2020.

Based on Glenmede Trust's 13F filing for Q2 2020, filed 14 Aug 2020.